Background To investigate the association between hypertension and clinical outcomes,
including in-hospital mortality, intensive care unit (ICU) admission, and invasive ventilation …

Objective: To investigate the association between hypertension and outcome in patients with
Coronavirus Disease 2019 (COVID-19) pneumonia. Methods: We performed a systematic …

Aims As reported, hypertension may play an important role in adverse outcomes of
coronavirus disease-2019 (COVID-19), but it still had many confounding factors. The aim of …

Despite the lack of direct evidence that hypertension increases the likelihood of new
infections, hypertension is known to be the most common comorbid condition in COVID-19 …

Background Since the COVID-19 outbreak, preliminary research has shown that some risk-
associated conditions increase death and severe complications of the disease, hypertension …

Background Comorbidities are commonly seen in patients with coronavirus disease 2019
(COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the …

Introduction: As the coronavirus disease 2019 (COVID-19) outbreak, identification of clinical
predictors of severe or fatal disease are necessary to enable risk stratification and optimize …

Aims It remains unknown whether the treatment of hypertension influences the mortality of
patients diagnosed with coronavirus disease 2019 (COVID-19). Methods and results This is …

Objectives: Hypertension is thought to be a contributor to mortality in coronavirus disease
2019 patients; however, limited clinical data on the outcomes of COVID-19 in patients with …

Previous studies have shown that common comorbidities were significantly associated with
the increased risk of adverse outcomes in patients with coronavirus disease 2019 (COVID …